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Summary We have examined the expression of several myeloid cell associated antigens, some of which are
involved in myelomonocyte adhesion, in seven well characterized human breast cancer cell lines, since
common properties of adhesiveness and migration are found in haemopoietic cells and epithelial cancer cells.
Five of these cell lines were of metastatic origin and two were derived from primary breast carcinoma.
Antigenic expression was evaluated by immunofluorescence (IF), flow cytometry (FCM), radioimmunoassay
on live cells (RIA) and immunoperoxidase staining. None of these cell lines expressed T or B lymphoid
specific antigens. Myeloid antigens My4, MO1, and MOF 11 (derived from the hybridization of mouse X63 -
Ag8 cells with spleen cells from Balb/c mice immunized with purified human monocytes) were expressed in
the 7 cell lines. Leu Ml, Leu M3, My9, and M02 antigens were expressed in some of the cell lines. Leu M2
and My7 antigens were not expressed or at very low levels. The expression of these myeloid antigens was also
tested by immunoperoxidase staining, and found on frozen sections of normal mammary gland, fibroadenoma
of the breast, primary breast cancer, and lymph node and skin metastases of breast tumours. This common
expression in epithelial breast cells and in myeloid cells might be related to common biological functions such
as interaction with extracellular matrix which precedes cell migration, a normal function of macrophages and
an abnormal function expressed or amplified in human cancer epithelial cells.
Recent reports have described the expression of myelo- included MCF7 (Soule et al., 1973), MDA-MB231 (Cailleau
monocyte associated antigens in small cell lung cancer cells et al., 1974), ZR75-1 (Engel et al., 1978), T47-D (Keydar et
(SCLC) (Ruff & Pert, 1984; Bunn et al., 1985; Ball et al., al., 1979) and H466B (Calvo et al., 1986) which were derived
1986; Gazdar et al., 1985) and advanced the hypothesis of a from metastatic breast carcinoma. Primary breast cancer
myeloid origin for this neoplasm (Ruff & Pert, 1984). Several lines were BT20 (Lasfargues & Ozzello, 1958) and HSL53 (F.
facts contradicted this conclusion, since myeloid antigen Calvo, unpublished). All cell lines were cultured in DMEM
expression was sometimes found in non SCLC lines (Bunn et (Gibco) supplemented with 10% foetal bovine serum except
al., 1985; Gazdar et al., 1985). Moreover certain leucocyte H466B in DMEM/F12 supplemented with hormones and
differentiation antigens such as those expressed on natural growth factors (Calvo et al., 1984) and 5% FBS. All these
killer (NK) cells and those constituting the CD10 complex cell lines are of epithelial morphology and positively react
(CALLA) were more consistently expressed in SCLC and with anti human milk fat globule membrane antigens and
neuroectodermal cells (Bunn et al., 1985; Efredimnis & Bekesi, anti epithelial cytokeratins antibodies.
1986; Lipinski et al., 1983; Cole et al., 1985), and there are
convincing biological data on the epithelial origin of SCLC
(Cole et al., 1985). Monoclonal antibodies (MoAb) Epithelial cells, either normal or malignant, interact with
constituents of basement membranes (BM). This interaction Anti My4 (IgGl, CD14), My7 (IgGI), My9 (IgG2b, CD33)
in normal cells, leads to their differentiation. With metastatic from Coulter (Hialeah, Florida) recognize antigenic deter-
cells, this interaction induces proteolysis of BM and minants on monocytes and acute myeloblastic leukaemias.
dissemination. Such interactions with BM, proteolysis and Anti Leu Ml (IgM), Leu M2 (IgM), Leu M3 (IgG2b) were
migration behaviour are basic properties of polymorpho- purchased from Becton Dickinson (Mountain View,
nuclear (PMN) and macrophages. The antigenic California). Leu Ml (CD15) is a human myeloid antigen
commonality observed in SCLC cells and those of myeloid (lacto N fucopentaose III) present on PMN and circulating
lineage could thus be related to the similar functional monocytes and was reported to be associated with adhesive
property of interaction with MB. In order to test this functions. Leu M2 is a membrane antigen of monocytes,
hypothesis, we have examined the expression of myeloid platelets and adherent macrophages. Leu M3 is a monocyte
associated antigens in several well characterized human macrophage antigen. Anti MO1 (IgM, CDl1) and anti M02
breast cancer cell lines and in biopsies of normal breast (IgM, CD14) were from Coulter (Hialeah, Florida). MOI is
gland, benign breast tumors and malignant primary or found on adherent monocytes, PMN and NK cells and
metastatic breast carcinoma. recognizes the C3bi receptor which is involved in adhesion of
These myeloid antigens are not yet functionally these cells. M02 is found on adherent monocytes and blast
characterized except two of them (Mol1 and Leu Ml) which cells from patients with myelomonocytic leukaemia.
are involved in adhesive processes (Dana et at., 1983; MOFl11 is a MoAb (IgG2b) derived from the hybridiza-
Arnaout et at., 1985; Symington et at., 1986). tion of mouse X63-AG8 cells with spleen cells from Balb/c
mice immunized with purified human monocytes. It identifies
an antigen present on monocytes, granulocytes and platelets
Materials and methods and was a gift of Dr Poncelet (Sanofi, Montpellier, France).
Cett tines Anti T and anti B MoAb tested were kindly offered by Dr Bernard-Boumsell (Paris, France); they recognize antigens of
Human breast carcinoma cell lines (HBCaCl) studied the following differentiation clusters: CDl, CD2, CD3, CD5,
CD7, CD8, CD10 (CALLA), and CD20 (Bi), CD22 (B2),
Correspondence: F. Calvo. CD21 (B4). OKT9 (anti transferrin receptor MoAb) was
Received 1 December 1986; and in revised form, 18 February 1987. purchased from Ortho-diagnostics (Raritan, NJ). Negative16 F. CALVO et ail.
control MoAbs included an antirotavirus (IgG) and anti- Fluorescence was consistently negative with the antibodies
oxoplasma (IgM) and were gifts from Dr Rosetto (Paris). recognizing B and T cell differentiation clusters. It was
positive with anti OKT9 MoAb which recognizes the trans-
Indirect immunofluorescence microscopy andfluorocytometric ferrin receptor. It was consistently positive with anti My4,
analysis MOI and MOFI I MoAb. Anti Leu Ml, Leu M2, and M02
Cell suspensions from cell lines were incubated with reacted diversely with the different cell lines tested. None of
the 7 cell lines reacted with anti MY7, anti My9 or expressed saturating concentration of the monoclonal antibody (106 Leu M3 anti en.
cells in 100,l at 4°C for 30min) washed twice, incubated g
with fluoresceinated goat anti mouse Ig of the appropriate Radioimmunoassay on live cells
class (Institut Pasteur, Paris, France) (1:50 dilution of
lmgml-' in 100p1 at 4°C for 30min) washed twice, and In order to obtain greater sensitivity, to quantify antigenic
analyzed for fluorescence using an inverted Zeiss fluorescence determinants and to try to discriminate between antigenic
microscope and/or an Ortho 50 fluorimeter (Ortho, expression on metastatic and primary breast cancer derived
California). For each cell line, samples were stained with a cell lines, a radioimmunoassay on live cells was performed.
non reactive primary antibody of the same class and the Seven cell lines were examined for the binding of the anti
secondary antibody, as negative control. My4, My7, My9, Leu Ml, Leu M2, Leu M3, MOl, M02
and MOFl 1 MoAbs.
Radioimmunoassay (RIA) on live cells As shown in Figure 1, all cell lines expressed antigenic
determinants recognized by anti My4, MO1 and MOFl1.
In order to quantify the antigenc .expression on the cell Significant binding of anti Leu MI was observed with
surface, a RIA on live cells was performted. MCF-7 and HSL 53. Anti My9, M02, and Leu M3 were
Biefly, cells were treated as above wlth the primary significantly bound by MCF-7 and BT20 respectively. No
antibody and were incubated with a Fab'2 25iodinated sheep obvious differences were observed between the five cell
antibody to mouse IgG and IgM (Amersham, France) (1/50 lines derived from breast cancer metastases (MCF7, MDA-
dilution of 1 mgml-1, 100p1, at 4°C for 30min), washed MB231, T47D, ZR75-1 and H466B) and the two cell lines twice, and counted with a gamma counter (LKB Wallac, established from primary breast cancer.
Turku, Finland). Nonspecific binding of negative controls
was subtracted. Immunoperoxidase staining ofcell lines andfrozen tissue
sections
Immunoperoxidase staining ofcell lines andfrozen sections of The immunoperoxidase staining patterns of malignant cell
tissues lines were similar to the immunofluorescence results, and a
Cell lines were cytocentrifuged (Shandon, London, England) heterogenous staining pattern was observed for each cell line
onto glass slides and fixed in cold acetone (4°C). Frozen (Figure 2A).
sections from normal breast biopsies, adenofibromas, breast Analysis of the frozen tissue sections demonstrated that
cancers, metastatic breast cancer, and cytocentrifuged some of the myeloid-monocytes antigens were expressed on
preparations were incubated with MoAb; immunoperoxidase fresh human breast cells (Figure 2B, C, D; Table II). Anti
staining was performed using the avidin-biotin peroxidase My4, Leu MI, Leu M2 and MOl stained non tumoral
technique (Hsu et al., 1981) (Vectastain, ABC Kit, Vector breast tissue and malignant breast tumours and the staining
Lab. Inc.) or a polyvalent antimouse immunoglobulin anti- was heterogenous. MOF11 positively stained malignant
body conjugated to peroxidase (Dakopatt, Denmark). tissues while weak staining was observed in normal cells and
Controls were the same as above. no staining on non malignant tumour cells. Finally anti Leu
M3 did not stain the tissue sections tested.
Results
Indirect immunofluorescence ofcell lines Discussion
Expression of the various antigens studied in the 7 human Epithelial cells interact with BM constituents. From this
breast cancer cell lines is shown in Table I. interaction, normal cells retain their differentiation charac-
Table I Immunofluorescence analysis of antibody reactivity with various cell lines of
breast cancer origin. +: positive; -: negative staining; *: % of positively stained cells
analyzed either by a cell sorter or by fluorescence microscopy; ND: not done.
Cell lines
Monoclonal
antibodies MCF-7 MDA-MB231 T47-D ZR75-1 H466B BT20 HSL53
Anti My4 +(42*) +(25) +(26) +(30) +(25) +(32) ND
AntiMy7 - - - - - - -
Anti My9
Anti Leu M1 +(72) _ +(12) +(20) +(38) +(10) +(54)
AntiLeuM2 - - - +(8) - - -
AntiLeuM3 - - - - - - -
Anti MOl1 +(45) +(18) +(24) +(22) ND ND +(52)
Anti M02 +(12) +(13) - - ND ND +(13)
MOF11 +(40) +(71) +(37) +(57) +(62) +(25) +(46)
Anti CD:
1-2-3
5-7-8-10
19-20-21 - - - - - - ND
AntiOKT9 + + + + + + +COMMON ANTIGENS OF MYELOMONOCYTIC AND BREAST CANCER CELLS 1X
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Figure 1 Binding of monoclonal antibodies against myelomonocyte antigens to human breast cancer cell lines. Data are expressed
as radioactivity bound (125lodinated Fab2 anti mouse immunoglobulin) to primary antibody per 106 cells.
2~~~~~~~~~~~~~
~~~~~~~~~~~..
Figure 2 Immunoperoxidase staining with anti myelomonocyte monoclonal antibodies. (A) Cytocentrifuged smears of MCF-7
cells stained with anti Leu Ml (x 250). (B) Frozen sections of skin metastasis of an adenocarcinoma of the breast stained with anti
LeuM1. Ep: Epidermal cells; M: metastic breast cancer cells (x250). (C) Frozen section of a primitive breast adenocarcinoma
stained with MOFl11 (x 250). (D) Frozen section of normal breast tissue sample stained with anti My4 ( x 250).18 F. CALVO et al.
Table II Reactivity of antimyelomonocytes monoclonal antibodies with frozen sections
of breast tissues (staining intensity is graded from + to + ++).
Monoclonal antibodies
Tissues My4 Leu Ml Leu M2 Leu M3 MO] MOFII
Normal breast tissue + ++ + ++ ++ - ++ +
Adenofibroma - + + + + ND + +
Subcutaneous metastasis + + ++ + - + + + +
Primary breast cancer + + ++ + +++ + + + + +
Lymph node metastasis + + + + + + + ND + + + +
teristics, and cancer cells respond by BM lysis and migration.
Macrophages also interact with BM and this is the first
event leading to migration.
The present data clearly show that antigenic determinants
present in the myeloid monocyte lineage are also present in
breast cancer cell lines, and, to various degrees, in fresh
sections of breast cancer and in non malignant mammary
gland. This expression of haemopoietic related antigens was
restricted to the myelomonocytic lineage since neither T nor
B differentiation antigens were exp.ressed in the breast cancer
cell lines tested. A common reactivity with these MoAbs
implies that either common surface antigens or at least
common epitopes are present in the different cell types
tested.
It was recently reported that some antigenic determinants
related to haemopoietic differentiation were expressed at the
cell surface of small cell lung cancer (SCLC) (Rtiff & Pert,
1984; Gazdar et al., 1985) and, to a lower extent, in
epidermoid carcinoma (Bunn et al, 1985). Similarly, an NK
cell antigen Leu 7, was expressed in SCLC and other
neuroendocrine tumours such as pheochromocytoma and
carcinoid tumours (Lipinski et al., 1983; Cole et al., 1985)
but could not be detected on epithelial tumours like breast
adenocarcinoma (Bunn et al., 1985). The Leu MI antigen
(lacto N fucopentaose III) has been shown to be present on
human colon and lung cancer and renal tubule (Huang et
al., 1983). The majority of the antigens reacting with the
MoAbs raised against myelomonocytes have not yet been
functionally characterized, and the biological significance of
the antigenic commonality may be only speculative.
However, some of these antigens have been associated with
the adhesive properties of PMN and macrophages.
Such antigenic sharing between different cell types, is
usually related to a common ontogeny. In fact, some of the
antigens tested here are common to monocytes, macro-
phages, PMN and their putative precursors. In SCLC, a
common ancestry with macrophages has been suggested by
Ruff and Pert (1984). However, this hypothesis is
controversial since SCLC seems to be of epithelial origin and
some lung epidermoid and glandular carcinoma cell lines
also share the same myeloid antigens (Bunn et al., 1985).
A second hypothesis implies the fusion of neoplastic cells
with host macrophages which could account for the
expression of macrophage differentiation associated antigens.
There is suggestive evidence that such spontaneous fusions
occur in vivo (Atkin, 1979; Kerbel et al., 1983; Larizza et al.,
1984), and are associated with a highly malignant phenotype.
However, in our study, no difference in binding was
observed between primary or metastatic derived cell lines.
Moreover, the staining of tissue sections with anti My4,
Leu Ml, Leu M2 and MOI did not discriminate between
normal, benign or primary and metastatic breast tissues. In
contrast, MOF11, which stained non malignant tissues
poorly, bound both primary and metastatic carcinoma cells
strongly.
The third hypothesis implies that the antigenic
commonality between myelomonocytes and epithelial cells
reflects common cell functions such as interaction with BM.
Indeed, normal and malignant epithelial cells and PMN and
monocytes share the common biological property of inter-
acting with basement membranes via several receptors and
molecular interactions (Giavazzi et al., 1983; Yamada, 1983;
Liotta, 1984; Hand et al., 1985; Charpin et al., 1986).
Normal breast epithelial cells attach to their basement
membrane constituted of collagen IV, laminin and glycos-
aminoglycans, and a permanent controlled proteolysis of this
barrier is associated to its synthesis (Yamada, 1983; Hand et
al., 1985; Charpin et al., 1986; Bano et al., 1986). These
interactions lead to the differentiation and polarization of
these cells (Gospodarowicz et al., 1978). Invasive tumours
also attach to their matrix but the proteolytic process seems
overexpressed and morphologically abnormal extracellular
matrices are synthetized at the interface between stroma and
tumour nodules (Charpin et al., 1986). Metastatic cells also
interact with basement membrane, but its degradation
predominates over synthesis (Liotta, 1984; Charpin et al.,
1986; Thorgeirrson et al., 1985; Liotta et al., 1980; Terranova
et al., 1986a). Phagocytes also adhere to constituents of
basement membrane, have laminin like receptors (Huard et
al., 1986), and laminin promotes their migratory ability
(Wright & Gallin, 1979; Terranova et al., 1986b). Proteolytic
activity and migration are secondary responses to adhesion
(Liotta, 1984; Thorgeirrson et al., 1985; Terranova et al.,
1986a; Wright & Gallin, 1979; Bano et al., 1986) and this
expression varies from normal epithelia to invasive tumours,
to metastatic cells and myelomonocytes. For instance, the
C3bi receptor present at the surface of neutrophils and
monocytes, is involved in adhesion (Arnaout et al., 1985) but
plays a pleiomorphic role in the morphology, oriented
mobility and proteolytic activity of these cells, as shown in
the genetic deficiency of this glycoprotein family where
adhesion, migration and proteolysis are abnormal (Dana et
al., 1983). As far as our study is concerned, the expansion of
antigens common to myeloid cells and cells of normal and
transformed epithelia could mean that none of them is
related to invasion but rather to the initial common step viz.
interaction with BM.
The authors thank Dr Poncelet (Laboratoires Sanofi, Montpellier,
France), Dr Jacquemier (Marseille) and Dr L. Bernard-Boumsell for
providing monoclonal antibodies, and Dr E. Solary for discussion of
these results.
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